BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 15888936)

  • 1. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; López-Ribot JL
    Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; Vande Walle K; Wickes BL; López-Ribot JL
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2475-9. PubMed ID: 11502517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditions for optimal Candida biofilm development in microtiter plates.
    Krom BP; Cohen JB; McElhaney-Feser G; Busscher HJ; van der Mei HC; Cihlar RL
    Methods Mol Biol; 2009; 499():55-62. PubMed ID: 19152039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC; Culici M; Alfieri M; Dal Sasso M
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
    Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
    Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.
    Pierce CG; Uppuluri P; Tummala S; Lopez-Ribot JL
    J Vis Exp; 2010 Oct; (44):. PubMed ID: 21048668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal susceptibility of Candida albicans in biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Presterl E
    Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM; Prigitano A; Biraghi E; Viviani MA;
    J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
    Bruzual I; Riggle P; Hadley S; Kumamoto CA
    J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
    Lamfon H; Porter SR; McCullough M; Pratten J
    J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
    Nailis H; Vandenbosch D; Deforce D; Nelis HJ; Coenye T
    Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
    J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sequence and structural properties on 14-helical beta-peptide activity against Candida albicans planktonic cells and biofilms.
    Karlsson AJ; Pomerantz WC; Neilsen KJ; Gellman SH; Palecek SP
    ACS Chem Biol; 2009 Jul; 4(7):567-79. PubMed ID: 19518070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents.
    Harrison JJ; Turner RJ; Ceri H
    FEMS Microbiol Lett; 2007 Jul; 272(2):172-81. PubMed ID: 17490429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.
    Jabra-Rizk MA; Shirtliff M; James C; Meiller T
    FEMS Yeast Res; 2006 Nov; 6(7):1063-73. PubMed ID: 17042756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microplate Alamar blue assay for susceptibility testing of Candida albicans biofilms.
    Repp KK; Menor SA; Pettit RK
    Med Mycol; 2007 Nov; 45(7):603-7. PubMed ID: 17885957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility testing of Candida tropicalis biofilms against fluconazole using calorimetric indicator resazurin.
    Punithavathy PM; Nalina K; Menon T
    Indian J Pathol Microbiol; 2012; 55(1):72-4. PubMed ID: 22499305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.